Top Markets
#1 Resolv wstUSR Resolv wstUSR +114.61%
#2 Luxxcoin Luxxcoin +45.15%
#3 ResearchCoin ResearchCoin +21.62%
#4 Reactive Network Reactive Network +21.45%
#5 Layer3 Layer3 +19.67%
#6 Orderly Network Orderly Network +16.55%
#7 Aria.AI Aria.AI +12.61%
#8 Bitgert Bitgert +11.76%
#9 Lisk Bridged wstETH (Lisk) Lisk Bridged wstETH (Lisk) +9.32%
#10 KAITO KAITO +9.04%
Coin of the day
Resolv wstUSR Resolv wstUSR
Innstillinger
Språk
NORSK
Valuta
USD
Tema
CSL Limited CSL Limited

CSL Limited

CSL
Rangering i aksjer #432
CSL Limited researches, develops, manufactures, markets, and distributes... CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The CSL Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.
Aksjekurs
$99.32
Markedsverdi
$48.20B
Endring (1 dag)
0.98%
Endring (1 år)
-32.14%
Land
AU
Handel CSL Limited (CSL)

Kategori

Healthcare
Utbytteavkastning for CSL Limited (CSL)
CSL Limited (aksjesymbol: CSL) sin utbytteavkastning (TTM) per 2024-06-30 er: 1.35%
Gjennomsnittlig utbytteavkastning de siste 5 årene: 1.54%
Utbytteavkastning for CSL Limited (CSL) fra 2000 til 2026
Utbytteavkastning ved slutten av hvert år (TTM)
År Utbytteavkastning Endre
2026 (TTM) 3.00% 59.57%
2025 1.88% 39.26%
2024 1.35% -25.41%
2023 1.81% 9.70%
2022 1.65% 66.67%
2021 0.99% 41.43%
2020 0.70% -39.13%
2019 1.15% 16.16%
2018 0.99% 2.06%
2017 0.97% -37.01%
2016 1.54% 18.46%
2015 1.30% -14.47%
2014 1.52% -7.88%
2013 1.65% -21.05%
2012 2.09% -19.62%
2011 2.60% 31.31%
2010 1.98% 47.76%
2009 1.34% 26.42%
2008 1.06% 23.26%
2007 0.86% -8.51%
2006 0.94% 28.77%
2005 0.73% 65.91%
2004 0.44% -76.84%
2003 1.90% 533.33%
2002 0.30% 15.38%
2001 0.26% -35.00%
2000 0.40% 0.00%
Utbytteavkastning (TTM) for lignende selskaper eller konkurrenter
Selskap Utbytteavkastning Land
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
4.14%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
0.46%
US
UCB SA UCB SA
UCB SA
UCB.BR
0.46%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL